Gland Pharma Share Price Target 2025 to 2040 Forecast & Fundamentals

Published on: September 24, 2024

Here, we are going to share Gland Pharma Share Price Target 2025 to 2040 on the basis of its fundamental and technical analysis.

Gland Pharma is a leading Indian pharmaceutical company specializing in injectable formulations. The company focuses on the development, manufacturing, and marketing of high-quality, complex injectables for both domestic and international markets.

If you are thinking to make a decision to invest in Gland Pharma Ltd company then this article could be very valuable for you as we are going to share all the important information like Gland Pharma Company Overview, Fundamentals, Quarterly Results, Profits and Loss, Competitors and Bear and Bull Case along with Gland Pharma Share Price Target 2025 to 2040.

Gland Pharma Ltd Company Overview

Founded: 1978
Founder: Mr PVN Raju
Headquarters: Hyderabad, India
No of Employees: Approx. 4,500
Listed in: NSE and BSE
Industry: Pharmaceuticals & Drugs
Key Areas of Focus: Manufacturing and marketing of complex injectables, primarily in the generic space
Global Presence: The company exports its products to over 60 countries including United States, Europe, Canada, and Australia.
Financial Performance: The company has shown consistent growth in revenue and profitability

Gland Pharma Share Key Information

Company Name	Gland Pharma Ltd
Headquarters	Hyderabad, India
Sectors	Pharmaceuticals & Drugs
Market Cap	₹ 30,565.56Cr.
No. of Shares	16.48 Cr.
Book Value	₹559.44
Dividend Yield	1.08%
ROCE	16.67%
ROE	12.31%
Face Value	₹1
Sales Growth	15.23%
Profit Growth	34.48%

Gland Pharma Business Sector

Injectables: Gland Pharma primarily manufactures and markets injectables, both for its own label and through partnerships with global pharmaceutical companies.

Contract Manufacturing: Gland Pharma provides contract manufacturing services for several multinational pharmaceutical companies, leveraging its manufacturing expertise and regulatory compliance capabilities.

Active Pharmaceutical Ingredients (APIs): The company also manufactures select APIs to support its formulations business, ensuring a stable and quality supply for its products.

Board Members

Srinivas Sadu – Chairman and CEO
Naina Lal Kidwai – Chair of the Audit Committee and board member
Essaji Goolam Vahanvati – Member of the Audit, Compensation, and Nominating Committees
Satyanarayna Murthy Chavali – Chair of the Audit, Compensation, and Nominating Committees
Wen Jie Zhang – Member of the Governance Committee and Nominating Committee
Udo Johannes Vetter – Member of the Compensation and Nominating Committees
Jia Ai Zhang – Director and board member

Gland Pharma Share Quarterly Results

PARTICULARS	Mar 2024	Jun 2024
Net Sales	1,174.83	1,012.02
Total Expenditure	742	718.47
Operating Profit	432.83	293.55
Other Income	46.96	48.49
Interest	4.53	0.91
Depreciation	42.56	40.82
Exceptional Items	0	0
Profit Before Tax	432.69	300.32
Tax	111.28	77.39
Profit After Tax	321.41	222.92
Adjusted EPS (Rs)	19.51	13.53

Also Read

Pfizer Ltd (PFIZER) Share Price Target 2025 to 2040 Forecast & Fundamentals

Gland Pharma Company Profits and Losses

PARTICULARS	Mar 2023	Mar 2024
Net Sales	3,616.53	4,167.43
Total Expenditure	2,597.98	2,758.65
Operating Profit	1,018.55	1,408.78
Other Income	240.46	166.67
Interest	7.41	7.84
Depreciation	146.74	162.11
Exceptional Items	-56.46	0
Profit Before Tax	1,048.40	1,405.50
Tax	272.58	362.17
Net Profit	775.83	1,043.33
Adjusted EPS (Rs.)	47.11	63.34

Gland Pharma Share Price Target 2025-2040

Year	Initial Target	Year-End Target
2025	₹1975	₹2025
2026	₹2033	₹2098
2027	₹2110	₹2182
2028	₹2191	₹2275
2029	₹2293	₹2402
2030	₹2425	₹2555
2035	₹3035	₹3450
2040	₹4150	₹4750

Also Read